Table S1.
Oligonucleotide primers used in this work
| Assays | Destination products | Template | Primer name | Primer sequence (5′-3′) |
| Y2H | AD-MED25 | MED25 | AD-MED25 F | CGGAATTCATGTCGTCGGAGGTGAAACAGCTGATCGT |
| AD-MED25 R | TTGGATCCCTCCCATGAAGCCAGCTCCAGGCATGTTA | |||
| BD-MED25 | MED25 | BD-MED25 F | CGGAATTCATGTCGTCGGAGGTGAAACAGCTGATCGT | |
| BD-MED25 R | TTGGATCCcTCCCATGAAGCCAGCTCCAGGCATGTTA | |||
| AD-COI1 | COI1 | AD-COI1 F | GGAATTCCATATGATGGAGGATCCTGATATCAAGA | |
| AD-COI1 R | TCCCCCCGGGTCATATTGGCTCCTTCAGGAC | |||
| AD-HAC1 | HAC1 | AD-HAC1 F | CCGGCCATGGAGGCCATGAATGTTCAGGCTCACATGT | |
| AD-HAC1 R | TCCCCCGGGGGACCTGAGCCCCCAGCGACTTC | |||
| AD-HAC5 | HAC5 | AD-HAC5 F | GGAATTCCATATGATGGCTCAGGGGCAGAATAGG | |
| AD-HAC5 R | CGCGGATCCGTCATTCAGGAGTGGAGGCCG | |||
| AD-HAC12 | HAC12 | AD-HAC12 F | CCGGCCATGGAGGCCATGAATGTTCAGGCTCAC | |
| AD-HAC12 R | TCCCCCGGGGGTCAACCCGAGGTTCCAGCGAC | |||
| AD-HAC11-894 | HAC1 | AD-HAC11-894 F | CCGGCCATGGAGGCCATGAATGTTCAGGCTCACATGT | |
| AD-HAC11-894 R | TCCCCCGGGGGTGTATGTTCAGTAGACTCTGCCA | |||
| AD-HAC1887-1,200 | HAC1 | AD-HAC1887-1,200 F | CCGGCCATGGAGGCCCTGGCAGAGTCTACTGAACATACA | |
| AD-HAC1887-1,200 R | TCCCCCGGGGGATAAACTCGGCGTTGATTGGGA | |||
| AD-HAC11,200-1,698 | HAC1 | AD-HAC11,200-1,698 F | CCGGCCATGGAGGCCCTCTCGTATTTGGATTCTG | |
| AD-HAC11,200-1,698 R | TCCCCCGGGGGACCTGAGCCCCCAGCGACTTC | |||
| AD-HAC11-710 | HAC1 | AD-HAC11-710 F | CCGGCCATGGAGGCCATGAATGTTCAGGCTCACATGT | |
| AD-HAC11-710 R | TCCCCCGGGGGCTTCACAGGAATACAGACAGG | |||
| AD-HAC1260-710 | HAC1 | AD-HAC1260-710 F | CCGGCCATGGAGGCCCCCATGATGGTACCTCAG | |
| AD-HAC1260-710 R | TCCCCCGGGGGCTTCACAGGAATACAGACAGG | |||
| AD-HAC1630-710 | HAC1 | AD-HAC1630-710 F | CCGGCCATGGAGGCCGATCCGAGATTCAAAAATC | |
| AD-HAC1630-710 R | TCCCCCGGGGGCACAGGAATACAGACAGGGCAG | |||
| LCI | MED25-nLUC | MED25 | MED25-nLUC F | CGGGATCCATGTCGTCGGAGGTGAAACAGCTGATCGT |
| MED25-nLUC R | ACGCGTCGACTCCCATGAAGCCAGCTCCAGGCATGTTA | |||
| MED25vWF-A-nLUC | MED25 | MED25-nLUC F | CGGGATCCATGTCGTCGGAGGTGAAACAGCTGATCGT | |
| MED25vWF-A-nLUC R | ACGCGTCGACCTCCGAGATCAGGACAAGATAGA | |||
| MED25MD-nLUC | MED25 | MED25MD-nLUC F | CGGGATCCATGAATTTTGTGGAGGCATGTGCTGCCT | |
| MED25MD-nLUC R | ACGCGTCGACGCCATCATCGGGGGCTATGCAG | |||
| MED25ACID-nLUC | MED25 | MED25ACID-nLUC F | CGGGATCCATGACTTCACAATCCAAATATGTGAA | |
| MED25ACID-nLUC R | ACGCGTCGACATTTGGAATTTGTGGTTTAAACA | |||
| MED25GD-nLUC | MED25 | MED25GD-nLUC F | CGGGATCCATGCAGCAACAGCAGCAGCAACAACAA | |
| MED25-nLUC R | ACGCGTCGACTCCCATGAAGCCAGCTCCAGGCATGTTA | |||
| cLUC-COI1 | COI1 | cLUC-COI1 F | CGGGGTACCATGGAGGATCCTGATATCAAGA | |
| cLUC-COI1 R | ACGCGTCGACTCATATTGGCTCCTTCAGGAC | |||
| cLUC-COI1F-box | COI1 | cLUC-COI1 F | CGGGGTACCATGGAGGATCCTGATATCAAGA | |
| cLUC-COI1F-box R | ACGCGTCGACCATAGTCACATGCTCTCTCGTCTC | |||
| cLUC-COI1LRR | COI1 | cLUC-COI1LRR F | CGGGGTACCGCGCTTTGCTACACTGCGACGCC | |
| cLUC-COI1 R | ACGCGTCGACTCATATTGGCTCCTTCAGGAC | |||
| cLUC-HAC1 | HAC1 | cLUC-HAC1 F | TCCCCCGGGATAATGTTCAGGCTCACATG | |
| cLUC-HAC1 R | ACGCGTCGACTTAACCTGAGCCCCCAGCGAC | |||
| Pull down | pMAL-MED25551-836 | MED25 | pMAL-MED25551-836 F | CGGGATCCATGACTTCACAATCCAAATATGTGAA |
| pMAL-MED25551-836 R | GAAGTCGACTTAGTGGTGGTGGTGGTGGTGTCCCAT | |||
| GAAGCCAGCTCCAGGCATGTTA | ||||
| pMAL-JAZ1 | JAZ1 | pMAL-JAZ1 F | CGGAATTCATGTCGAGTTCTATGGAATGTTCTG | |
| pMAL-JAZ1 R | CGGGATCCGTGGTGGTGGTGGTGGTGTATTTCAGCT | |||
| GCTAAACCGAGC | ||||
| pET28a-COI1 | COI1 | pET28a-COI1 F | GGAATTCCATATGATGGAGGATCCTGATATCAAGA | |
| pET28a-COI1 R | ACGCGTCGACTCATATTGGCTCCTTCAGGAC | |||
| Antibody | pET28a-HAC1 | HAC1 | pET28a-HAC1 F | GCGTCGACGTAATGTTCAGGCTCACATGTCG |
| pET28a-HAC1 R | ATAAGAATGCGGCCGCTACCTGAGCCCCCAGCGAC | |||
| pMAL-MYC2 | MYC2 | pMAL-MYC2 F | GCTAGCATGACTGATTACCGGCTACAAC | |
| pMAL-MYC2 R | CTGCAGACCGATTTTTGAAATCAAACTTGC | |||
| Transformation | pHAC1:HAC1-GFP | HAC1 promoter | HAC1 promoter F | AAACTGCAGGTGAGTTTTGAGATCGATATG |
| HAC1 promoter R | ACGCGTCGACAGCTACCTCTTCAGTCTC | |||
| HAC1 | HAC1 CDS F | ACGCGTCGACATGAATGTTCAGGCTCAC | ||
| HAC1 CDS R | TCCCCCGGGGACCTGAGCCCCCAGCGAC | |||
| GFP | GFP F | GAAGGTACCATGGTGAGCAAGGGCGAGG | ||
| GFP R | GAATTCCTTGTACAGCTCGTCCATGCCGA | |||
| p35S:JAZ1-GFP | JAZ1 | JAZ1 F | CACCATGTCGAGTTCTATGGAATG | |
| JAZ1 R | TATTTCAGCTGCTAAACCGAGCC | |||
| p35S:MED25-Flag | MED25 | MED25 F | CACCATGTCGTCGGAGGTGAAACAGCTGATCGT | |
| MED25 R | TCCCATGAAGCCAGCTCCAGGCATGTTA | |||
| p35S:MYC2-Flag | MYC2 | MYC2 F | CACCATGACTGATTACCGGCTACA | |
| MYC2 R | ACCGATTTTTGAAATCAAACTTGC | |||
| ChIP | JAZ8 | JAZ8-A F | GTTGTCGAAGTTTGTTGGTAGG | |
| JAZ8-A R | CTCGGTTGCAATTGTATCAAC | |||
| JAZ8-B F | AAAACCTTAAAGTTGCACAAATG | |||
| JAZ8-B R | TTTACAACGGCGGACTCTTAG | |||
| JAZ8-C F | TGTCCTCTCTCTCCTCACAAATAG | |||
| JAZ8-C R | ATAAGAAGTGGGAAAAAGACGAAG | |||
| JAZ8-D F | GATCGCAAGCAGAGAAATGA | |||
| JAZ8-D R | TATCGTCGTGAATGGTACGG | |||
| ERF1 | ERF1-A F | TATCGTATCAAAGGTCTCTCCCAA | ||
| ERF1-A R | GCAACATTTTCTGTCGTTCGGA | |||
| ERF1-B F | AAGAGATACAATGTCCAGGTTT | |||
| ERF1-B R | ATTAGAACACTACACATCATCACA | |||
| ERF1-C F | TCAATCCACTAACGATCCCTAA | |||
| ERF1-C R | TTAGAAGAAGAGGATGAGAAAGAA | |||
| ERF1-D F | GGCGGAGAGAGTTCAAGAGT | |||
| ERF1-D R | TCCGTCTCATCGAGTGTTTC | |||
| ACTIN7 | ACT7 F | CCATAGCATTGTCTCTCCCA | ||
| ACT7 R | CGGCAGCAGCTAACACTAAG | |||
| qRT-PCR | VSP1 | VSP1 F | CCTCGAATCGAACACCATCT | |
| VSP1 R | GGCACCGTGTCGAAGTTTAT | |||
| PDF1.2 | PDF1.2 F | CGCACCGGCAATGGTGGAAG | ||
| PDF1.2 R | CACACGATTTAGCACCAAAG | |||
| JAZ8 | JAZ8 F | TCGTCTTTTTCCCACTTCTTATGA | ||
| JAZ8 R | AAGTCATCCTCAAACGGGTCG | |||
| ERF1 | ERF1 F | GGAAATTCGCGGCGGAGATAAGA | ||
| ERF1 R | CAACGCCACAACCGGAGAACAAC | |||
| HAC1 | HAC1 F | CCCGATGAAGGAGGACTTTA | ||
| HAC1 R | TCCCTGTCTTCACGTCTCTG | |||
| MED25 | MED25 F | GTCAAATGTCGCTTCAAACC | ||
| MED25 R | CTGCCACCAAGTTGTTGTATT | |||
| ACTIN7 | ACTIN7 F | CCATTCAGGCCGTTCTTTC | ||
| ACTIN7 R | CGTTCTGCGGTAGTGGTGA |
ACID, activator-interacting domain; F, forward; GD, glutamine-rich domain; MD, middle domain; R, reverse.